Abstract
Summary
To determine whether the hypotensive effects of meprobamate or mebutamate could be related to a renal action, experiments were performed using the conscious, trained beagle in which urinary electrolytes and renal clearances were measured. Electrolytes were not affected by intravenous doses of 1–90 mg/kg of meprobamate or 10–50 mg/kg, of mebutamate. Clearance of inulin and p-aminohippurate were measured using doses of 30 mg/kg of meprobamate and 20 mg/kg of mebutamate. Neither clearance was affected by meprobamate, and there was only a small reduction in PAH clearance following mebutamate administration. It was concluded that these compounds are without significant renal effects.
Get full access to this article
View all access options for this article.
